Montoya, A, Mody, L. Common infections in nursing homes: a review of current issues and challenges. Aging Health 2011;7:889–899.
Jones, AL, Dwyer, LL, Bercovitz, AR, Strahan, GW. The National Nursing Home Survey: 2004 overview. Vital Health Stat 13 2009;167:1–155.
European Centre for Disease Prevention and Control. Point Prevalence Survey of Health Care-Associated Infections and Antimicrobial Use in European Long-Term Care Facilities. April–May 2013. Stockholm: ECDC; 2014.
Wagenlehner, F, Tandogdu, Z, Bartoletti, R, et al. the global prevalence of infections in urology study: a long-term, worldwide surveillance study on urological infections. Pathogens 2016;5:10.
Chopra, T, Goldstein, EJC. Clostridium difficile infection in long-term care facilities: a call to action for antimicrobial stewardship. Clin Infect Dis 2015;60 suppl 2:S72–S76.
Denkinger, CM, Grant, AD, Denkinger, M, Gautam, S, D’Agata, EM. Increased multi-drug resistance among the elderly on admission to the hospital—a 12-year surveillance study. Arch Gerontol Geriatr 2013;56:227–230.
Sloane, PD, Kistler, CE, Reed, D, Weber, DJ, Ward, K, Zimmerman, S. Urine culture testing in community nursing homes: gateway to antibiotic overprescribing. Infect Control Hosp Epidemiol 2017;38:524–531.
Cormican, M, Murphy, AW, Vellinga, A. Interpreting asymptomatic bacteriuria. BMJ 2011;343:d4780.
Phillips, CD, Adepoju, O, Stone, N, et al. Asymptomatic bacteriuria, antibiotic use, and suspected urinary tract infections in four nursing homes. BMC Geriatr 2012;12:73.
Goossens, H, Ferech, M, Vander Stichele, R, Elseviers, M. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005;365(9459):579–587.
Cek, M, Tandoğdu, Z, Wagenlehner, F, Tenke, P, Naber, K, Bjerklund-Johansen, TE. Healthcare-associated urinary tract infections in hospitalized urological patients—a global perspective: results from the GPIU studies 2003–2010. World J Urol 2014;32:1587–1594.
Horcajada, JP, Shaw, E, Padilla, B, et al. Healthcare-associated, community-acquired and hospital-acquired bacteraemic urinary tract infections in hospitalized patients: a prospective multicentre cohort study in the era of antimicrobial resistance. Clin Microbiol Infect 2013;19:962–968.
Benoit, SR, Nsa, W, Richards, CL, et al. Factors associated with antimicrobial use in nursing homes: a multilevel model. J Am Geriatr Soc 2008;56:2039–2044.
Gupta, K, Hooton, TM, Naber, KG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 2011;52(5):e103–e120.
Gurwitz, JH, Field, TS, Avorn, J, et al. Incidence and preventability of adverse drug events in nursing homes. Am J Med 2000;109:87–94.
Tandan, M, Cormican, M, Vellinga, A. Adverse events of fluoroquinolones vs. other antimicrobials prescribed in primary care: a systematic review and meta-analysis of randomized controlled trials. Int J Antimicrob Agent 2018;52:529–540.
Tanne, JH. FDA adds “black box” warning label to fluoroquinolone antibiotics. BMJ 2008;337(7662):135.
Clinical and Laboratory Standard Institute. Perfomance Standard for Antimicrobial Susceptability Testing—16th Informational Supplement. Wayne, PA: CLSI document M100-S18; 2008.
Sievert, DM, Ricks, P, Edwards, JR, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009–2010. Infect Control Hosp Epidemiol 2015;34:1–14.
Magiorakos, AP, Srinivasan, A, Carey, RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012;18:268–281.
Gupta, K, Hooton, TM, Stamm, WE. Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections. Ann Intern Med 2001;135:41–50.
Flores-Mireles, AL, Walker, JN, Caparon, M, Hultgren, SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nature Rev Microbiol 2015;13:269.
Rowe, TA, Juthani-Mehta, M. Diagnosis and management of urinary tract infection in older adults. Infect Dis Clin N Am 2014;28:75–89.
Florio, W, Tavanti, A, Barnini, S, Ghelardi, E, Lupetti, A. Recent advances and ongoing challenges in the diagnosis of microbial infections by MALDI-TOF mass spectrometry. Front Microbiol 2018;9:1097.
Sloane, PD ZS, Ward, K, Kistler, KE, et al. Implementing antibiotic stewardship in community nursing homes: a two-year dissemination trial. Manuscript currently in review. 2018.
Elligsen, M, Walker, SAN, Pinto, R, et al. Audit and feedback to reduce broad-spectrum antibiotic use among intensive care unit patients a controlled interrupted time series analysis. Infect Control Hosp Epidemiol 2015;33:354–361.
Dortch, MJ, Fleming, SB, Kauffmann, RM, Dossett, LA, Talbot, TR, May, AK. Infection reduction strategies including antibiotic stewardship protocols in surgical and trauma intensive care units are associated with reduced resistant gram-negative healthcare-associated infections. Surg Infect 2011;12:15–25.
Jenkins, TC, Knepper, BC, Shihadeh, K, et al. Long-term outcomes of an antimicrobial stewardship program implemented in a hospital with low baseline antibiotic use. Infect Control Hosp Epidemiol 2015;36:664–672.
del Arco, A, Tortajada, B, de la Torre, J, et al. The impact of an antimicrobial stewardship programme on the use of antimicrobials and the evolution of drug resistance. Eur J Clin Microbiol Infect Dis 2015;34:247–251.
Ikram, R, Psutka, R, Carter, A, Priest, P. An outbreak of multi-drug resistant Escherichia coli urinary tract infection in an elderly population: a case-control study of risk factors. BMC Infect Dis 2015;15:224.
FDA Drug Safety Communication: FDA updates warnings for oral and injectable fluoroquinolone antibiotics due to disabling side effects. US Food and Drug Administration website. https://www.fda.gov/Drugs/DrugSafety/ucm500143.htm. Published 2016. Accessed July 4, 2018.
Goltsman, G, Mizrahi, EH, Leibovitz, A, Gal, G, Gorelik, O, Lubart, E. Comparative characteristic of antimicrobial resistance in geriatric hospital: a retrospective cohort study. Aging Clin Exper Res 2018;30:839–843.
Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: 22nd Informational Supplement. Wayne, PA: CLSI; 2012.
Lutgring, JD, Limbago, BM. The problem of carbapenemase-producing carbapenem-resistant Enterobacteriaceae detection. J Clin Microbiol 2016;54:529–534.